Targeted drug delivery using biodegradable implants
Controlled focal drug delivery by endovascular bioresorbable composite implants
['FUNDING_R03'] · UNIVERSITY OF CALIFORNIA RIVERSIDE · NIH-11092191
This study is looking at new implants that can deliver medicine right to places like tumors or inflamed areas in your body, helping to treat conditions more effectively while causing fewer side effects.
Quick facts
| Phase | ['FUNDING_R03'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA RIVERSIDE (nih funded) |
| Locations | 1 site (RIVERSIDE, UNITED STATES) |
| Trial ID | NIH-11092191 on ClinicalTrials.gov |
What this research studies
This research focuses on developing innovative implants that can deliver drugs directly to specific areas of the body, such as tumors or inflamed tissues, while minimizing side effects. By using bioresorbable composite materials, these implants can release medication precisely where it's needed and then safely dissolve in the body. This approach aims to reduce the harmful effects associated with traditional drug delivery methods, which often affect other organs. Patients may benefit from more effective treatments with fewer adverse reactions.
Who could benefit from this research
Good fit: Ideal candidates include individuals with localized conditions such as tumors, inflammatory bowel disease, or focal epilepsy.
Not a fit: Patients with systemic diseases or those who do not have focal disease processes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective treatments for various focal diseases.
How similar studies have performed: Previous research has shown promise in targeted drug delivery technologies, but this specific approach using bioresorbable implants is relatively novel.
Where this research is happening
RIVERSIDE, UNITED STATES
- UNIVERSITY OF CALIFORNIA RIVERSIDE — RIVERSIDE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ZAGHA, EDWARD W — UNIVERSITY OF CALIFORNIA RIVERSIDE
- Study coordinator: ZAGHA, EDWARD W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.